Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with IFL in Advanced Colorectal Cancer
NCT00006786Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Nov 2000
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Eastern Cooperative Oncology Group. Started Nov 2000; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006786.